To produce a clinically useful dose-response
relationship we need:
Large studies of women in the general population
–
patients who have comorbidities or complicated
problems are not usually entered into trials
Long follow-up
•
Data on non-fatal as well as fatal events
•
Sufficient detail to calculate cardiac doses
•
Information on pre-existing risk factors, eg prior
heart disease